About Esanik Therapeutics
Esanik Therapeutics is a private company based in Northville, Michigan. It has reported $3,478,915 raised in two offerings on Form D since November 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Apr 30, 2026 | $200,000of $375K target | 1 | $200K | Equity, DebtRule 506(b) | Form D ↗ |
| Oct 31, 2024 | Nov 14, 2024 | $3,278,915fully sold | 4 | $819K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $3,478,915 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Esanik Therapeutics's Form D filed Apr 30, 2026.
JS
John Sorensen
President and director